Roberto Mina, MD, details how in the MajesTEC-9 trial, teclistamab monotherapy boosted PFS and OS in relapsed/refractory multiple myeloma, challenging standardized care.
Prolia works similarly to alendronate by slowing down the cells that break down bone, called osteoclasts. Unlike alendronate and similar drugs, Prolia stops working as soon as you stop taking it, so ...
Unlike alendronate and similar drugs, Prolia stops working as soon as you stop taking it, so people who are on it need to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results